Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans (Diabetologia, 10.1007/s00125-017-4479-9)

Rebecca K.C. Loh; Melissa F. Formosa; Nina Eikelis; David A. Bertovic; Mitchell J. Anderson; Shane A. Barwood; Shane Nanayakkara; Neale D. Cohen; Andre La Gerche; Anne T. Reutens; Kenneth S. Yap; Thomas W. Barber; Gavin W. Lambert; Martin H. Cherk; Stephen J. Duffy; Bronwyn A. Kingwell; Andrew L. Carey

doi:10.1007/s00125-017-4514-x

Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans (Diabetologia, 10.1007/s00125-017-4479-9)

Rebecca K.C. Loh, Melissa F. Formosa, Nina Eikelis, David A. Bertovic, Mitchell J. Anderson, Shane A. Barwood, Shane Nanayakkara, Neale D. Cohen, Andre La Gerche, Anne T. Reutens, Kenneth S. Yap, Thomas W. Barber, Gavin W. Lambert, Martin H. Cherk, Stephen J. Duffy, Bronwyn A. Kingwell, Andrew L. Carey

Medicine Alfred Hospital

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Abstract

The baseline insulin data given in Table 1 for the placebo group were incorrectly reported as 51 ± 10 pmol/l instead of 48 ± 10 pmol/l. This mistake also impacts on data reported in Table 4. The authors also note an error in the reported change in noradrenaline levels, from pre- to post-pioglitazone treatment (Table 4). The relevant rows from Tables 1 and 4 are reproduced here, with corrected data shown in bold. These corrections do not change the statistical significance of any comparison. (Table presented.).

Original language	English
Pages (from-to)	504-505
Number of pages	2
Journal	Diabetologia
Volume	61
Issue number	2
DOIs	https://doi.org/10.1007/s00125-017-4514-x
Publication status	Published - 1 Feb 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00125-017-4514-x

Cite this

Loh, R. K. C., Formosa, M. F., Eikelis, N., Bertovic, D. A., Anderson, M. J., Barwood, S. A., Nanayakkara, S., Cohen, N. D., La Gerche, A., Reutens, A. T., Yap, K. S., Barber, T. W., Lambert, G. W., Cherk, M. H., Duffy, S. J., Kingwell, B. A., & Carey, A. L. (2018). Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans (Diabetologia, 10.1007/s00125-017-4479-9). Diabetologia, 61(2), 504-505. https://doi.org/10.1007/s00125-017-4514-x

@article{e775c352084f4e2494e81e21e78edda0,

title = "Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans (Diabetologia, 10.1007/s00125-017-4479-9)",

abstract = "The baseline insulin data given in Table 1 for the placebo group were incorrectly reported as 51 ± 10 pmol/l instead of 48 ± 10 pmol/l. This mistake also impacts on data reported in Table 4. The authors also note an error in the reported change in noradrenaline levels, from pre- to post-pioglitazone treatment (Table 4). The relevant rows from Tables 1 and 4 are reproduced here, with corrected data shown in bold. These corrections do not change the statistical significance of any comparison. (Table presented.).",

author = "Loh, {Rebecca K.C.} and Formosa, {Melissa F.} and Nina Eikelis and Bertovic, {David A.} and Anderson, {Mitchell J.} and Barwood, {Shane A.} and Shane Nanayakkara and Cohen, {Neale D.} and {La Gerche}, Andre and Reutens, {Anne T.} and Yap, {Kenneth S.} and Barber, {Thomas W.} and Lambert, {Gavin W.} and Cherk, {Martin H.} and Duffy, {Stephen J.} and Kingwell, {Bronwyn A.} and Carey, {Andrew L.}",

note = "Publisher Copyright: {\textcopyright} 2017, Springer-Verlag GmbH Germany, part of Springer Nature.",

year = "2018",

month = feb,

day = "1",

doi = "10.1007/s00125-017-4514-x",

language = "English",

volume = "61",

pages = "504--505",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer-Verlag London Ltd.",

number = "2",

}

Loh, RKC, Formosa, MF, Eikelis, N, Bertovic, DA, Anderson, MJ, Barwood, SA, Nanayakkara, S, Cohen, ND, La Gerche, A, Reutens, AT, Yap, KS, Barber, TW, Lambert, GW, Cherk, MH, Duffy, SJ, Kingwell, BA & Carey, AL 2018, 'Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans (Diabetologia, 10.1007/s00125-017-4479-9)', Diabetologia, vol. 61, no. 2, pp. 504-505. https://doi.org/10.1007/s00125-017-4514-x

Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans (Diabetologia, 10.1007/s00125-017-4479-9). / Loh, Rebecca K.C.; Formosa, Melissa F.; Eikelis, Nina et al.
In: Diabetologia, Vol. 61, No. 2, 01.02.2018, p. 504-505.

Research output: Contribution to journal › Comment / Debate › Other › peer-review

TY - JOUR

T1 - Correction to

T2 - Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans (Diabetologia, 10.1007/s00125-017-4479-9)

AU - Loh, Rebecca K.C.

AU - Formosa, Melissa F.

AU - Eikelis, Nina

AU - Bertovic, David A.

AU - Anderson, Mitchell J.

AU - Barwood, Shane A.

AU - Nanayakkara, Shane

AU - Cohen, Neale D.

AU - La Gerche, Andre

AU - Reutens, Anne T.

AU - Yap, Kenneth S.

AU - Barber, Thomas W.

AU - Lambert, Gavin W.

AU - Cherk, Martin H.

AU - Duffy, Stephen J.

AU - Kingwell, Bronwyn A.

AU - Carey, Andrew L.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - The baseline insulin data given in Table 1 for the placebo group were incorrectly reported as 51 ± 10 pmol/l instead of 48 ± 10 pmol/l. This mistake also impacts on data reported in Table 4. The authors also note an error in the reported change in noradrenaline levels, from pre- to post-pioglitazone treatment (Table 4). The relevant rows from Tables 1 and 4 are reproduced here, with corrected data shown in bold. These corrections do not change the statistical significance of any comparison. (Table presented.).

AB - The baseline insulin data given in Table 1 for the placebo group were incorrectly reported as 51 ± 10 pmol/l instead of 48 ± 10 pmol/l. This mistake also impacts on data reported in Table 4. The authors also note an error in the reported change in noradrenaline levels, from pre- to post-pioglitazone treatment (Table 4). The relevant rows from Tables 1 and 4 are reproduced here, with corrected data shown in bold. These corrections do not change the statistical significance of any comparison. (Table presented.).

UR - http://www.scopus.com/inward/record.url?scp=85037665571&partnerID=8YFLogxK

U2 - 10.1007/s00125-017-4514-x

DO - 10.1007/s00125-017-4514-x

M3 - Comment / Debate

C2 - 29222583

AN - SCOPUS:85037665571

SN - 0012-186X

VL - 61

SP - 504

EP - 505

JO - Diabetologia

JF - Diabetologia

IS - 2

ER -

Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans (Diabetologia, 10.1007/s00125-017-4479-9)

Abstract

UN SDGs

Access to Document

Other files and links

Research output

Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans

Cite this